The Impact of Ultrasound-Guided Rectus Sheath Blocks on Intraoperative Anesthetic Requirements and Early Recovery in Laparoscopic Surgery: A Retrospective Cohort Study
- 1Department of Anesthesia, Dubai Hospital, Dubai Health, Dubai, ARE
Abstract
Background and objective
The rectus sheath block (RSB) is increasingly utilized for multimodal analgesia in abdominal surgeries. A properly administered RSB may reduce nociceptive input, thereby lowering the requirement for systemic opioids and intravenous anesthetic agents such as propofol, as well as sedative/analgesic adjuncts such as dexmedetomidine. Moreover, effective regional blockade may attenuate the surgical stress response, contributing to more hemodynamic stability and reducing the use of vasopressors like phenylephrine. This retrospective study aims to evaluate the intraoperative impact of ultrasound-guided RSB in adult patients undergoing laparoscopic abdominal surgery.
Methods
This retrospective, comparative observational study included 331 adult patients with American Society of Anesthesiologists (ASA) physical status I-III, who underwent elective laparoscopic appendectomy, cholecystectomy, or midline ventral hernia repair (including umbilical and midline incisional hernias). Patients were stratified into an intervention cohort receiving ultrasound-guided RSB (block group, n = 126) and a standard care cohort (no-block group, n = 205). As a non-randomized retrospective study, block allocation was determined by the attending anesthesiologist's discretion, largely influenced by provider preference and operative time constraints. Primary outcomes included the total intraoperative opioid dose (calculated as morphine equivalents), total intravenous anesthetic dose (propofol), and sedative/analgesic adjunct (dexmedetomidine). Secondary outcomes included vasopressor requirement (phenylephrine), time spent in the post-anesthesia care unit (PACU), sedation level at PACU admission, and duration of oxygen supplementation, which may serve as surrogate markers for oversedation related to intraoperative drug administration.
Results
Baseline demographic and surgical characteristics were well matched. The block group demonstrated a significant reduction in intraoperative opioid consumption compared to the no-block group (median: 5.0 vs. 9.0 morphine milligram equivalents, p < 0.001), with multivariable adjustment confirming a 62.4% reduction in modelled exposure (p < 0.001). However, total intraoperative doses and infusion rates of propofol, dexmedetomidine, and phenylephrine demonstrated no statistically significant differences between the cohorts. Regarding recovery, the RSB was associated with a 72% reduction in the adjusted odds of presenting to the PACU with a modified Aldrete score < 9 (OR: 0.28, p < 0.001). Prolonged oxygen supplementation (>30 min) and overall PACU time did not differ significantly.
Conclusions
In laparoscopic abdominal surgery, ultrasound-guided RSB serves as a highly effective intraoperative opioid sparing adjunct that significantly enhances immediate functional recovery and PACU discharge readiness. However, the block does not significantly reduce the intraoperative requirements for intravenous anesthetics (propofol), sedative adjuncts (dexmedetomidine), or vasopressors (phenylephrine), indicating its primary intraoperative utility lies in opioid reduction rather than comprehensive anesthetic-sparing or hemodynamic modulation.
Related
- Association between anesthetic fresh gas flow and postoperative inflammatory response in laparoscopic sleeve gastrectomy : A retrospective cohort study
- Effect of ultrasound-guided stellate ganglion block on intraoperative hemodynamics in laparoscopic partial adrenalectomy: a randomized clinical trial
- Effect of Etomidate Induction on Intraoperative Hemodynamics, Postoperative Inflammation, and Recovery After Laparoscopic Sleeve Gastrectomy: A Retrospective Cohort Study.
- The impact of intraoperative use of the inhaled anesthetic desflurane on postoperative recovery quality after noncardiac surgery: a meta-analysis of randomized controlled trials
- Functional and Structural Neuroanatomic Correlates of Intraoperative Anesthetic Dose-Adjusted EEG Alpha Power Among Older Surgical Patients
BibTeX
@article{abdelhamid2026impact,
title = {{The Impact of Ultrasound-Guided Rectus Sheath Blocks on Intraoperative Anesthetic Requirements and Early Recovery in Laparoscopic Surgery: A Retrospective Cohort Study}},
author = {Sherin Abdelhamid and Khaled Abuamra and Ahmed A Khalaf and Hatem Ibrahim and Ahmad Nabil},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.116947},
url = {https://doi.org/10.7759/cureus.116947},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The Impact of Ultrasound-Guided Rectus Sheath Blocks on Intraoperative Anesthetic Requirements and Early Recovery in Laparoscopic Surgery: A Retrospective Cohort Study
AU - Sherin Abdelhamid
AU - Khaled Abuamra
AU - Ahmed A Khalaf
AU - Hatem Ibrahim
AU - Ahmad Nabil
PY - 2026
DA - 2026/09/25
JO - Cureus
DO - 10.7759/cureus.116947
UR - https://doi.org/10.7759/cureus.116947
AB - Background and objective The rectus sheath block (RSB) is increasingly utilized for multimodal analgesia in abdominal surgeries. A properly administered RSB may reduce nociceptive input, thereby lowering the requirement for systemic opioids and intravenous anesthetic agents such as propofol, as well as sedative/analgesic adjuncts such as dexmedetomidine. Moreover, effective regional blockade may attenuate the surgical stress response, contributing to more hemodynamic stability and reducing the use of vasopressors like phenylephrine. This retrospective study aims to evaluate the intraoperative impact of ultrasound-guided RSB in adult patients undergoing laparoscopic abdominal surgery. Methods This retrospective, comparative observational study included 331 adult patients with American Society of Anesthesiologists (ASA) physical status I-III, who underwent elective laparoscopic appendectomy, cholecystectomy, or midline ventral hernia repair (including umbilical and midline incisional hernias). Patients were stratified into an intervention cohort receiving ultrasound-guided RSB (block group, n = 126) and a standard care cohort (no-block group, n = 205). As a non-randomized retrospective study, block allocation was determined by the attending anesthesiologist's discretion, largely influenced by provider preference and operative time constraints. Primary outcomes included the total intraoperative opioid dose (calculated as morphine equivalents), total intravenous anesthetic dose (propofol), and sedative/analgesic adjunct (dexmedetomidine). Secondary outcomes included vasopressor requirement (phenylephrine), time spent in the post-anesthesia care unit (PACU), sedation level at PACU admission, and duration of oxygen supplementation, which may serve as surrogate markers for oversedation related to intraoperative drug administration. Results Baseline demographic and surgical characteristics were well matched. The block group demonstrated a significant reduction in intraoperative opioid consumption compared to the no-block group (median: 5.0 vs. 9.0 morphine milligram equivalents, p < 0.001), with multivariable adjustment confirming a 62.4% reduction in modelled exposure (p < 0.001). However, total intraoperative doses and infusion rates of propofol, dexmedetomidine, and phenylephrine demonstrated no statistically significant differences between the cohorts. Regarding recovery, the RSB was associated with a 72% reduction in the adjusted odds of presenting to the PACU with a modified Aldrete score < 9 (OR: 0.28, p < 0.001). Prolonged oxygen supplementation (>30 min) and overall PACU time did not differ significantly. Conclusions In laparoscopic abdominal surgery, ultrasound-guided RSB serves as a highly effective intraoperative opioid sparing adjunct that significantly enhances immediate functional recovery and PACU discharge readiness. However, the block does not significantly reduce the intraoperative requirements for intravenous anesthetics (propofol), sedative adjuncts (dexmedetomidine), or vasopressors (phenylephrine), indicating its primary intraoperative utility lies in opioid reduction rather than comprehensive anesthetic-sparing or hemodynamic modulation.
SN - 2168-8184
ER -